Healio (2/18, Gramigna) reports, “Early improvements of individual symptoms might contribute to later treatment response among patients with Alzheimer’s disease receiving antipsychotics for neuropsychiatric symptoms,” researchers concluded after analyzing “data from the Clinical Antipsychotic Trials of Intervention Effectiveness-Alzheimer’s Disease,” which “included data from 421 patients with DSM-IV Alzheimer’s Disease receiving antipsychotics for neuropsychiatric symptoms.” The findings of the “re-analysis study” were published online in the Journal of Clinical Psychiatry.
Related Links:
— “Early individual symptom response to antipsychotics impacts later response in patients with Alzheimer’s
, “Joe Gramigna, Healio, February 18, 2020